News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
682,103 Results
Type
Article (57987)
Company Profile (233)
Press Release (623869)
Multimedia
Podcasts (139)
Webinars (23)
Section
Business (191895)
Career Advice (2694)
Deals (34600)
Drug Delivery (131)
Drug Development (79772)
Employer Resources (194)
FDA (16662)
Job Trends (14008)
News (331614)
Policy (33870)
Tag
Academia (2538)
Academic (1)
Accelerated approval (18)
Adcomms (35)
Allergies (119)
Alliances (44733)
ALS (139)
Alzheimer's disease (1654)
Antibody-drug conjugate (ADC) (250)
Approvals (16686)
Artificial intelligence (433)
Autoimmune disease (95)
Automation (25)
Bankruptcy (356)
Best Places to Work (10540)
BIOSECURE Act (23)
Biosimilars (160)
Biotechnology (170)
Bladder cancer (135)
Brain cancer (50)
Breast cancer (490)
Cancer (3901)
Cardiovascular disease (338)
Career advice (2269)
Career pathing (37)
CAR-T (245)
CDC (57)
Cell therapy (660)
Cervical cancer (30)
Clinical research (66756)
Collaboration (1322)
Company closure (4)
Compensation (945)
Complete response letters (61)
COVID-19 (2858)
CRISPR (79)
C-suite (580)
Cystic fibrosis (133)
Data (4607)
Decentralized trials (2)
Denatured (35)
Depression (109)
Diabetes (432)
Diagnostics (6174)
Digital health (28)
Diversity (8)
Diversity, equity & inclusion (49)
Drug discovery (197)
Drug pricing (189)
Drug shortages (33)
Duchenne muscular dystrophy (201)
Earnings (87129)
Editorial (55)
Employer branding (24)
Employer resources (165)
Events (99960)
Executive appointments (929)
FDA (19148)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1154)
Gene editing (168)
Generative AI (37)
Gene therapy (539)
GLP-1 (1005)
Government (4749)
Grass and pollen (8)
Guidances (370)
Healthcare (17046)
HIV (46)
Huntington's disease (40)
IgA nephropathy (62)
Immunology and inflammation (251)
Immuno-oncology (22)
Indications (54)
Infectious disease (3093)
Inflammatory bowel disease (183)
Inflation Reduction Act (14)
Influenza (96)
Intellectual property (191)
Interviews (495)
IPO (16906)
IRA (56)
Job creations (3801)
Job search strategy (1885)
Kidney cancer (16)
Labor market (81)
Layoffs (626)
Leadership (36)
Legal (8088)
Liver cancer (87)
Longevity (12)
Lung cancer (555)
Lymphoma (259)
Machine learning (30)
Management (62)
Manufacturing (625)
MASH (140)
Medical device (12590)
Medtech (12611)
Mergers & acquisitions (18600)
Metabolic disorders (1130)
Multiple sclerosis (136)
NASH (23)
Neurodegenerative disease (218)
Neuropsychiatric disorders (61)
Neuroscience (2664)
NextGen: Class of 2025 (5769)
Non-profit (3674)
Now hiring (60)
Obesity (557)
Opinion (299)
Ovarian cancer (136)
Pain (165)
Pancreatic cancer (173)
Parkinson's disease (234)
Partnered (28)
Patents (414)
Patient recruitment (322)
Peanut (54)
People (53554)
Pharmaceutical (48)
Pharmacy benefit managers (28)
Phase I (20511)
Phase II (29212)
Phase III (22582)
Pipeline (2751)
Policy (293)
Postmarket research (2608)
Preclinical (8552)
Press Release (66)
Prostate cancer (197)
Psychedelics (51)
Radiopharmaceuticals (262)
Rare diseases (668)
Real estate (5421)
Recruiting (75)
Regulatory (24630)
Reports (65)
Research institute (2319)
Resumes & cover letters (434)
Rett syndrome (16)
RNA editing (15)
RSV (67)
Schizophrenia (134)
Series A (198)
Series B (152)
Service/supplier (12)
Sickle cell disease (76)
Special edition (26)
Spinal muscular atrophy (156)
Sponsored (40)
Startups (3459)
State (1)
Stomach cancer (17)
Supply chain (96)
Tariffs (96)
The Weekly (103)
Vaccines (1037)
Venture capital (66)
Weight loss (397)
Women's health (50)
Worklife (21)
Date
Today (84)
Last 7 days (757)
Last 30 days (2695)
Last 365 days (30964)
2025 (25789)
2024 (34920)
2023 (39433)
2022 (50550)
2021 (54440)
2020 (51590)
2019 (42407)
2018 (32206)
2017 (33015)
2016 (31720)
2015 (35933)
2014 (30778)
2013 (26559)
2012 (26455)
2011 (26972)
2010 (25131)
Location
Africa (860)
Alabama (70)
Alaska (6)
Arizona (229)
Arkansas (12)
Asia (40910)
Australia (6929)
California (9193)
Canada (2592)
China (852)
Colorado (365)
Connecticut (415)
Delaware (268)
Europe (95729)
Florida (1381)
Georgia (281)
Hawaii (3)
Idaho (55)
Illinois (684)
India (45)
Indiana (443)
Iowa (18)
Japan (325)
Kansas (112)
Kentucky (26)
Louisiana (17)
Maine (71)
Maryland (1246)
Massachusetts (6802)
Michigan (271)
Minnesota (539)
Mississippi (3)
Missouri (105)
Montana (22)
Nebraska (21)
Nevada (102)
New Hampshire (72)
New Jersey (2574)
New Mexico (22)
New York (2479)
North Carolina (1264)
North Dakota (9)
Northern California (4278)
Ohio (267)
Oklahoma (17)
Oregon (36)
Pennsylvania (1886)
Puerto Rico (14)
Rhode Island (33)
South America (1211)
South Carolina (49)
South Dakota (1)
Southern California (3556)
Tennessee (138)
Texas (1403)
United States (33281)
Utah (258)
Virginia (218)
Washington D.C. (72)
Washington State (756)
West Virginia (4)
Wisconsin (84)
Wyoming (1)
682,103 Results for "wong s biotech stock report".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Special edition
Deep Dive: Chinese Biotech Innovation Can’t Be Stopped
In this deep dive,
BioSpace
investigates China’s rise as a biotech powerhouse.
October 27, 2025
·
3 min read
·
Annalee Armstrong
IPO
SPACs Line Up To Clear Biotech’s IPO Backlog
Blank check deals dwindled after a crazy 2021. Now, biotechs are starting to turn to special purpose acquisition companies again as an easy route to the public markets.
September 3, 2025
·
6 min read
·
Annalee Armstrong
FDA
Krystal Biotech’s FDA Platform Designation Pushes Limits of the Award
The company’s technology, a modified herpes simplex virus used to deliver gene therapies, was given the FDA’s new designation based on its approved topical skin cream. What this will mean for Krystal’s still-in-development eye drop is unclear.
October 21, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
October 29, 2025
·
9 min read
Press Releases
Oncolytics Biotech® Announces Voluntary Delisting from the Toronto Stock Exchange
August 11, 2025
·
4 min read
Job Trends
Report: U.S. Life Sciences Job Market Report Q3 2025
BioSpace’s Q3 2025 U.S. Life Sciences Job Market Report reveals a turbulent quarter for biopharma hiring, with record declines in job postings, rising layoffs, and cautious employer sentiment shaping the industry’s employment landscape.
October 16, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Krystal Biotech to Report Third Quarter 2025 Financial Results on November 3, 2025
October 22, 2025
·
1 min read
Venture capital
Biotech Markets Turn Positive but Experts Say Don’t Call It a Comeback—Yet
M&A is back, the S&P XBI is rising again, a biotech pulled off an IPO and positive data is pulling in investors again. This may just be the industry’s new normal.
October 22, 2025
·
7 min read
·
Annalee Armstrong
Mergers & acquisitions
Tang Capital’s Concentra on Buyout Binge With Plenty of Biotech Fodder
After a slow 2024, the biotech shell company Concentra Biosciences is back, offering to buy four biotechs in the past month and seven so far this year.
August 13, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Neopharma Technologies Appoints Singapore Fintech Veteran and Serial Entrepreneur Mr. Joo Seng Wong as Board Advisor to Oversee Institutional Strategy and Global Execution
October 9, 2025
·
2 min read
1 of 68,211
Next
